321 related articles for article (PubMed ID: 31042582)
1. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
Rich NE; Yopp AC; Singal AG; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
[TBL] [Abstract][Full Text] [Related]
2. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
[TBL] [Abstract][Full Text] [Related]
3. Geographic variation within the United States in the incidence of hepatocellular carcinoma.
Davila JA; Petersena NJ; Nelson HA; El-Serag HB
J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
Altekruse SF; McGlynn KA; Reichman ME
J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
[TBL] [Abstract][Full Text] [Related]
7. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.
Zhang X; El-Serag HB; Thrift AP
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271
[TBL] [Abstract][Full Text] [Related]
8. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.
Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD
Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665
[TBL] [Abstract][Full Text] [Related]
9. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
[TBL] [Abstract][Full Text] [Related]
11. Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER-22, 2000-2019.
O'Brien TR; Devesa SS; Koshiol J; Marrero JA; Shiels MS
Cancer Med; 2023 Oct; 12(19):19960-19967. PubMed ID: 37776201
[TBL] [Abstract][Full Text] [Related]
12. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014.
Islami F; DeSantis CE; Jemal A
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):429-439. PubMed ID: 29902641
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma - United States, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
[TBL] [Abstract][Full Text] [Related]
14. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
Ryerson AB; Eheman CR; Altekruse SF; Ward JW; Jemal A; Sherman RL; Henley SJ; Holtzman D; Lake A; Noone AM; Anderson RN; Ma J; Ly KN; Cronin KA; Penberthy L; Kohler BA
Cancer; 2016 May; 122(9):1312-37. PubMed ID: 26959385
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic status and hepatocellular carcinoma in the United States.
Shebl FM; Capo-Ramos DE; Graubard BI; McGlynn KA; Altekruse SF
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1330-5. PubMed ID: 22669949
[TBL] [Abstract][Full Text] [Related]
16. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA
Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis.
Chen C; Jiang Y; Yang F; Cai Q; Liu J; Wu Y; Lin H
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):640-648. PubMed ID: 33051117
[TBL] [Abstract][Full Text] [Related]
18. The effects of race and ethnicity on thyroid cancer incidence.
Magreni A; Bann DV; Schubart JR; Goldenberg D
JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):319-23. PubMed ID: 25654447
[TBL] [Abstract][Full Text] [Related]
19. Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012.
Pham C; Fong TL; Zhang J; Liu L
J Natl Cancer Inst; 2018 Nov; 110(11):1259-1269. PubMed ID: 29617913
[TBL] [Abstract][Full Text] [Related]
20. Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States.
Han SS; Kelly SP; Li Y; Yang B; Nguyen M; So S; Rosenberg PS; Hsing AW
J Natl Cancer Inst; 2019 Jun; 111(6):550-556. PubMed ID: 30544184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]